|
|
Suppliers for
Granisetron
|
Properties | CAS |
109889-09-0 | Formula |
C18H24N4O |
|
|
9 Registered suppliers
Molecular Formula: C18H24N4O Molecular Weight: 312,41
More details are to be found here
Molecular Formula: C18H24N4O Molecular Weight: 312,41
More details are to be found here
Molecular Formula: C18H24N4O Molecular Weight: 312,41
More details are to be found here
Description : Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull - Molecular Weight :312.42
- Melting Point :290-292°C
- Purity :> 95%
Molecular Formula : C18H24N4O Canonical SMILES : MFWNKCLOYSRHCJ-AGUYFDCRSA-N InChI : InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ InChIKey : MFWNKCLOYSRHCJ-AGUYFDCRSA-N Solubility : 25°C: DMSO Appearance : White to yellowish white crystalline powder Application : Granisetron is an antagonist of serptpmom 5-HT3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Storage : -20ºC Freeze Synonyms : 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694
More details are to be found here
Description : Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull - Molecular Weight :312.42
- Melting Point :290-292°C
- Purity :> 95%
Molecular Formula : C18H24N4O Canonical SMILES : MFWNKCLOYSRHCJ-AGUYFDCRSA-N InChI : InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ InChIKey : MFWNKCLOYSRHCJ-AGUYFDCRSA-N Solubility : 25°C: DMSO Appearance : White to yellowish white crystalline powder Application : Granisetron is an antagonist of serptpmom 5-HT3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Storage : -20ºC Freeze Synonyms : 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694
More details are to be found here
Description : Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull - Molecular Weight :312.42
- Melting Point :290-292°C
- Purity :> 95%
Molecular Formula : C18H24N4O Canonical SMILES : MFWNKCLOYSRHCJ-AGUYFDCRSA-N InChI : InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ InChIKey : MFWNKCLOYSRHCJ-AGUYFDCRSA-N Solubility : 25°C: DMSO Appearance : White to yellowish white crystalline powder Application : Granisetron is an antagonist of serptpmom 5-HT3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Storage : -20ºC Freeze Synonyms : 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694
More details are to be found here
Description : Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull - Molecular Weight :312.42
- Melting Point :290-292°C
- Purity :> 95%
Molecular Formula : C18H24N4O Canonical SMILES : MFWNKCLOYSRHCJ-AGUYFDCRSA-N InChI : InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ InChIKey : MFWNKCLOYSRHCJ-AGUYFDCRSA-N Solubility : 25°C: DMSO Appearance : White to yellowish white crystalline powder Application : Granisetron is an antagonist of serptpmom 5-HT3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Storage : -20ºC Freeze Synonyms : 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694
More details are to be found here
Description : Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull - Molecular Weight :312.42
- Melting Point :290-292°C
- Purity :> 95%
Molecular Formula : C18H24N4O Canonical SMILES : MFWNKCLOYSRHCJ-AGUYFDCRSA-N InChI : InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ InChIKey : MFWNKCLOYSRHCJ-AGUYFDCRSA-N Solubility : 25°C: DMSO Appearance : White to yellowish white crystalline powder Application : Granisetron is an antagonist of serptpmom 5-HT3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Storage : -20ºC Freeze Synonyms : 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694
More details are to be found here
|
Properties:
... more properties and specification on Granisetron
|
|
Privileged suppliers
Last update 2024-05-17
|